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Cyclic nucleotides have important functions in the cellular slime mold Dict-yostelium discoideum. This organism lives in the soil where it feeds on bacteria. When the food supply is exhausted the single cells aggregate to form a multicellular slug, which finally differentiates into a fruiting body. Cell aggregation is mediated by chemotaxis to CAMP, which is detected by cell surface receptors. Extracellular cAMP induces a rapid transient accumulation of intracellular cGMP levels, which reach a maximal concentration after about 10 s (for reviews see [l -31) .
D. discoidewn cells contain two classes of cyclic nucleotide phosphodiesterase activity. One class of enzymes hydrolyzes cAMP and cGMP with similar rates; these enzymes are located extracellularly, intracellularly and on the cell surface [4-61. A second class of enzymes hydrolyzes only cGMP and is localized only intracellularly [7 - 91. Non-specific phosphodiesterase is present in large excess over the cCMP-specific enzyme. These enzyme activities can be easily separated by concanavalin-A -Sepharose column chromatography, since all CAMP-hydrolyzing activity binds to the column, while the cGMP-specific enzyme passes through the column [8] .
Mutant cells have been isolated which are totally devoid of the cGMP-specific enzyme [lo, 111. Transduction of chemotactic signals in these mutant cells indicate that cGMP is involved in the chemotactic reaction and that in wild-type cells cCMP is degraded mainly by the cCMP-specific enzyme [121.
Detailed kinetic studies have shown that the cGMPspecific enzyme is activated about threefold by low cGMP concentrations, which is due to a decrease of K,, while V,,, is unaltered. Half-maximal activation occurs at about 0.1 pM cGMP; it is a second-order process with a half-life of about 20 s at 0.1 pM cGMP [13] . The use of cGMP derivatives has revealed that the enzyme has two distinct cGMP sites, one for activation of the enzyme and another for hydrolysis by the enzyme; e.g. cAMP binds to neither site, cIMP binds only to the catalytic site, and 8-bromoguanosine 3',5'-monophosphate binds preferentially to the activator site [S, 141. cGMP-stimulated phosphodiesterases have been observed in many organisms and tissues . They differ from the slime mold enzyme in molecular mass and in cyclic nucleotide specificity; the mammalian enzyme also hydrolyzes cAMP [16, 171. In with the activator site and the catalytic site of the cGMPspecific phosphodiesterase from D. discoideum is described.
The results show that the derivatives may have very different affinities for both sites. Furthermore, we show that each derivative may activate the enzyme to a different extent. A mechanism on the activation process is proposed, which is based on the differential stabilization of an activated and nonactivated enzyme species by cGMP derivatives. [13] of the method of Casnellie et al. [18] . The reversed-phase packing material, pBondapak C1,/Porasil BI 35 -75 pm, was obtained from Waters; concanava1in-ASepharose was from Pharmacia, and Dowex AGlX2 was from Serva. DEAE-Sepharose and snake venom (Ophiopkugus hannah) were purchased from Sigma. Compounds 1, 2, 3, 4, 12, 19 and 20 (see Fig, 1 Compounds 15 and 16 (PS) and (PR) isomers respectively of guanosine 3',5'-mono[thio]phosphate, were synthesized according to the procedure for the synthesis of the analogous derivatives of CAMP [22] with some essential modifications. The 2'-OH and 2-NH2 functions of cCMP were protected by isobutyryl groups in a reaction of cGMP (tri-n-butylammonium salt, 0.53 g, 1 mmol) with isobutyric anhydride (3.3 ml, 20 mmol) and 4-dimethylaminopyridine (0.25 g, 2 mmol) in 30 ml dimethylformamide (reaction time: 24 h; isolation: flash chromatography; yield: 75%). Then N2,02'-diisobutyrylguanosine 3',5'-monophosphate (0.41 g, 0.6 mmol) was converted to the diastereoisomeric mixture of N2,02'-diisobutyrylguanosine 3 (15 and 16) were synthesized from the correspondent anilidates in stereospecific reaction with sodium hydride and carbon disulphide [22] : S31P(D20) = 54.9 ppm for (PS) isomer Isolation of' the cCMP-spec@ phosphodiestevase D. discoideum NC4H cells were grown as described in [13] . Cells were starved in suspension for 2 h. All subsequent steps were carried out at 0-4°C. Cells were homogenized by sonication. The homogenate was centrifuged at 23000 x g for 10 min and the supernatant at 42000 x g for 1 h. The supernatant (8 ml derived from 8 x 10' cells) was applied to a concanavalin-A -Sepharose column (160 mm x 16 mm diam-eter) and the column was eluted with 10 mM sodium/ potassium phosphate buffer, pH 7.2. The fractions eluting between 18 ml and 43 ml were combined and applied to a DEAE-Sepharose column (120 mm x 9 mm diameter) at a flow rate of 25 ml h-'. Then the column was eluted at a flow rate of 16 ml h-' with 50 ml10 mM phosphate buffer pH 7.2, followed by 85 ml 50 mM NaCl in the same buffer, and with 100 ml of a linear gradient of NaCl (0.05-0.2 M) in buffer. Fractions of 4 ml were collected and assayed for phosphodiesterase activity and protein concentrations. The fractions which contained the highest specific activity were combined and used in the experiments. In some experiments the enzyme was concentrated using Minicon B15 (Amicon).
MATERIALS AND METHODS

Materials
Protein concentrations were determined according to the method of Lowry et al. [23] . Each experiment was performed with duplicate or triplicate incubations on at least three different enzyme preparations.
Plz osplz odies f erase assays
Three assays to quantify the enzymatic hydrolysis of cyclic nucleotides have been used. Assay I, which has been used to map the activator site, was essentially identical to the procedure described in [8, 131 . Briefly, the incubations (200 pI) contained 10 nM [3H]cIMP (about 2 kBq), cyclic nucleotides, 10 mM phosphate buffer pH 7.5, and 150 p1 enzyme. After 30 min at 22°C the incubation was terminated by boiling the samples during 2 min. The product, [3H]5'IMP was converted to [3H]inosine by snake venom, and the substrate, [3H]cIMP, removed by addition of 1 ml ion-exchanger. After centrifugation the radioactivity in the supernatant was determined.
Assay 11, which has been used to map the catalytic site, is based on a separation technique by reversed-phase chromatography as described in [24] . Briefly, the incubation (100 pl) contained 20 pM ['HIcIMP (1.5 kBq), cyclic nucleotides, buffer, and 30 pl enzyme. The incubation was terminated after 60 min at 22°C by the addition of 25 p140 mM H3P04 which reduces the pH to 3.0. Then 125 pl was applied to small reversed-phase columns, which were eluted at atmospheric pressure with 1.2 ml 1 % methanol in phosphate buffer pH 3.0 (yielding [3H]5'IMP) followed by 1.2 ml 50% methanol in buffer (yielding [3H]cIMP).
Assay 111, which has been used to measure the hydrolysis of all cGMP derivatives, was essentially identical to a procedure described previously [25] . Briefly, the incubations (20 pl) contained 50 pM cGMP or cCMP drivative, 10mM phosphate buffer, pH 7.2, and 10 p1 enzyme (which was concentrated 50-fold by Minicon B15, Amicon). The reaction was terminated after 60 min at 22°C by adding 25 p14 mM H3P04 which reduces the pH to 4.0. Samples were centrifuged at 8000 x g for 2 min, and 20 p1 of the supernatant were analyzed by high-performance liquid chromatography by using the anion-exchanger Partisil PXS, 10/25 SAX eluted with 25 mM KH2P04, 5% methanol, pH 4.5.
The accumulation of product was linear with time for all assays, provided that not more than 40% of the substrate was hydrolysed.
RESULTS
Isolation and parrial purification qf ihe cGMP-specqic phosphod~es~er~se
In a crude homogenate of D . discoideum cells, CAMP and cGMP are hydrolyzed at approximately equal rates, since the nonspecific enzyme, which hydrolyzes both CAMP and cGMP, is in large excess over the cGMP-specific enzyme. The separation of the cCMP-specific enzyme from the nonspecific enzyme by concanavalin-A -Sepharose column chromatography has been described previously [8] . It has been shown that the cGMP-specific phosphodiesterase isolated by this procedure is activated by low cGMP concentrations and that activation of the enzyme by cGMP and hydrolysis of cGMP occur at different sites of the enzyme.
Both the catalytic activity and the activation property of the enzyme were measured during the purification procedure. Ammonium sulphate precipitation can not be used, due to the loss of catalytic activity; DEAE-cellulose column chromatography, which has been used by others to isolate the cGMP-specific enzyme from D. discoideum [7, 9] , is not useful in this experiment, since the activation property is largely lost. Affinity chromatography on a matrix in which the ligand 8-NH2(CH2)2-S-cGMP is coupled to CNBr-activated Sepharose is not successful, because the described method for the affinity ligdnd [26] does not yield 8-NH2-(CH2)2-S-cCMP in our hands. Affinity chromatography on a matrix in which cGMP is immobilized on epoxy-activated Sepharose [I71 can not be used, since the cGMP-specific enzyme elutes from the column with a wash step containing 10 mM NaCl. This can be expected since cGMP is bound to the Sepharose column via its 2-amino or 2'-hydroxy groups [17] and both groups are required to obtain binding of cGMP to the activator site of the Dictjmteliunz cGMP-specific enzyme [8, 141. DEAE-Sepharose column chromatography has been found to be the only procedure so far to purify the enzyme without losing activatability or catalytic properties. cGMPhydrolyzing activity elutes as a single peak at about 0.12 M NaCl (Fig. 2) . Elution with NaCl up to 0.4 M does not result in another fraction containing cCMP-hydrolyzing activity. The fractions with the highest specific activity are purified about 10-fold compared to the crude homogenate; the yield is about 25%. The activation of the enzyme by cGMP is completely preserved in this chromatography step. The enzyme is stable at 2°C for at least four days, without losing catalytic or activating properties.
Sikrion qf rGM P d u ivatives cGMP can form several interactions with its surrounding medium (water or protein), such as hydrogen bonds, ionic bonds, and hydrophobic interactions. The derivatives were selected to reduce or remove one interaction potential. A possible hydrogen bond is prevented in compound 2 at N2H2, in compound 3 at N2H2 and N3, in compound 4 at N2Hz, N'H and C60, in compound 5 at N', in compound 12 at 02'H, in compound 13 at 03', and in compound 14 at 0'' (see Fig. 1 ). The activity of these compounds may reveal the involvement of one of the mentioned hydrogen bonds in the binding of cGMP to the protein. The data from A are transformed to a linear plot [13] . cpm* is the amount of substrate hydrolyzed in thc absence of any derivative, and cpm that in the presence of the mentioned cGMP derivatives. The intercept on the absciwi equals -K : I , whilc the intersection with the ordinate equals (a-1)-', where a is the maximal-fold activation
Specificity of the activutor site
Previously [I31 it has been shown that cIMP is a good substrate of the cGMP-stimulated cGMP-specific phosphodiesterase from D. discoideum, but that it does not activate the enzyme. Therefore we used ['HIcIMP as the substrate of the enzyme.
Activation of the hydrolysis of 10nM [3H]cIMP by compounds 1 (cGMP), 5 , 8 and 15 is shown in Fig. 3A . These data were then transformed to a plot [I31 shown in Fig. 3B .
The intersection with the abscissa equals -K L 1 ; K, is the apparent activation constant (concentration of derivative which induces half-maximal activation). The intersection with the ordinate equals (a-1)-I where a is the maximal-fold activation. The result with all derivatives are summarized in Table 1 . It appears that some analogs can activate the enzyme 6.6-fold, while others activate only 2.3-fold.
A few derivatives do not activate the enzyme. This could imply that they do not bind to the activator site, or that they do bind to the activator site, but are unable to activate ( i s .
Tdbk I . Properties qf rhc cGMP derivatives K, is the apparent activation constant of the derivative [concentration which induces half-maximal activation of the hydrolysis of [3H]~IMP]. a is the maximal-fold activation; data between parentheses mean that the derivatives do not bind to the activator site. ICjo is the concentration or derivative which induces a 50% inhibition of the hydrolysis of 20 pM clMP as determincd in Fig. 5 (1) they are full antagonists). Discrimination beween these possibilities can be made by investigating whether the derivatives can inhibit the activation induced by bscGMP (compound 8). The experiment is shown in Fig. 4 for three derivatives. Compound 6 activates the enzyme almost to the same extent as bscGMP does. By addition of increasing concentrations of compound 6 to an incubation containing b8cCMP, an exchange between b8cGMP and derivative 6 will occur at the activator site. Because compound 6 and b*cCMP activate the enzyme to the same extent, no alteration of 
enzyme activity occurs. Compound 14 activates the enzyme only twofold. The fivefold activation by bscGMP is reduced by compound 14 to a threefold activation. Thus compound 14 exchanges with bscGMP at the activator site. Compound 17 does not activate the enzyme. Since it does not reduce the activation by b*cGMP it appears that compound 17 does not bind to the activator site. Similar experiments were done with compounds 2, 3, 4, 12, 19 and 20 which indicate that none of them binds to the activator site.
Spwificiiy qf the cntulytic siie
The interaction of cyclic nucleotide derivatives with the catalytic site of a cCMP-stimulated phosphodiesterase from rat liver has been determined by detecting the inhibition of the hydrolysis of substrate by the completely activated enzyme [16] . For the present enzyme this would imply that the enzyme is activated by bscGMP, and that the inhibition of the hydrolysis of [3H]cIMP by the derivatives is measured. However, the derivatives activate the enzyme to a different extent. Thus the addition of, for instance, cGMP to the incubation mixture may result in an exchange with bscGMP at the activator site (which reduces the hydrolysis of [3H]cIMP, because cGMP does not activate the enzyme as strongly as b8cGMP), or cGMP may exchange with [3H]cIMP at the catalytic site (which also reduces the hydrolysis of [3H]cIMP).
The procedure we use to establish the interaction of the cGMP derivatives with the catalytic site is shown for cGMP, b8cGMP, and compound 12 in Fig. 5 . Enzyme activity is measured at 20 pM [3H]cIMP, because activation at higher substrate concentrations is small (this is due to the fact that V,,, is not altered by the derivatives; e.g. bscGMP activates the enzyme only 2.5-fold). The data at low analog concentrations are transformed to the plot (Fig. 5, top) 
The activator site
Binding of cGMP to the activator site is strongly diminished (more than 80-fold) if a hydrogen bond at N2H2 or 0 2 ' H cannot be formed. Binding of cGMP to the activator site is diminished 20-fold if a hydrogen bond at 03' or 05' cannot be formed, while binding is reduced only slightly if a putative hydrogen bond at N7 is impaired. Some of the analogs modified at the 8 position bind better to the activator site than cGMP, and some of them bind worse. The energy contribution of a hydrogen bond to the binding energy of a ligand to a protein is above 10 kJ/mol 1331 which is proportional to a 60-fold reduction of binding affinity. Therefore, we tentatively propose that cGMP is bound to the activator site via hydrogen bonds at N2H2 and 0 2 ' H . Hydrogen bonds at N7, 03' and 05' are absent. The involvement of hydrogen bonds at N'H, N 3 , and C 6 0 in the binding of cGMP to the activator site remains unknown, because analogs specifically modified at these atom groups are not available.
A stereoselective recognition of the phosphate moiety at the activator site is indicated by the data for compounds 15 -18; modification of the apical exocyclic oxygen atom by sulphur (compound 15) does not change the binding affinity, while modification of the equatorial exocyclic oxygen atom (compound 16) reduces the binding affinity 90-fold. The uncharged compounds 17 and 18 do not bind to the activator site up to 0.1 mM. The nature of the interaction between the phosphorus moiety and the activator site of the enzyme are not completely resolved by the present data. A covalent bond, as was suggcstcd for other cyclic nucleotide binding proteins 1341, seems unlikely, because compound 15 would have reduced affinity, and compound 17 would not be inactive. A charge-charge interaction is possible if it is directed to the equatorial exocyclic oxygen atom (cf. compounds 15 and 16) .
A similar influence on the biological activity by sulphur substitution has been observed for the correspondent cAMP[S] derivatives in Escherichia Cali where the (PR) isomer has very high biological activity, while the (PS) isomer has only low activity [35] . In this case an H-bond-directed ion pair betwecn an arginine in the CAMP-acceptor protein and the axial oxygen atom in CAMP was determined by X-ray analysis [36] .
Recently it has been shown that some of the CAMP derivatives analogous to compounds 15 -18 may have CAMP antagonizing activities in several CAMP-dependent reactions 127-321. None of the cGMP derivatives 15-18 are antagonists for the present enzyme, since compounds which bind to the activator site also activate the enzyme. the maximal-fold activation is obtained. With this value the activity of the enzyme without inhibition at the catalytic site is known for the derivative (loo%, Fig. 5 ). Then the analog concentration which inhibits this value by 50% is called IC50. ICSo values (Table 1) range from 14 pM to concentrations above 10 mM. Some derivatives do not inhibit the hydrolysis of cIMP at even the highest derivative concentrations (which is generally 1 mM); apparently, these derivatives do not bind to the catalytic site.
Degvadution of cyclic nucleotides
A second characteristic of the catalytic site, besides the binding of a substrate molecule, is the enzymatic conversion of the substrate. Degradation of all cCMP derivatives was measured by high-performance liquid chromatography. Only eight derivatives were found to be hydrolyzed; the other derivatives were hydrolyzed at least 50-fold slower than cGMP (see Table 1 ).
DISCUSSION
In this report the apparent activation constant, the maximal-fold activation, the apparent inhibition constant and
The catalytic site cGMP is bound to the catalytic site quite differently from its binding to the activator site of the enzyme (Table 1) . Binding of cGMP to the catalytic site is stronlgy diminished if cGMP is modified at N'H/C60, C8, 03', and at the exocyclic oxygen atoms. Modifications at N2H2, N3, N7, 02'H, and 05' have only minor effects on the binding affinity of cGMP to the catalytic site. Therefore, we propose that cGMP is bound to the catalytic site via hydrogen bonds at N'H and/ Tentative models of the interaction of cGMP with the activator site and the catalytic site are shown in Fig. 6 . Both sites have recognition points in the guanine moiety, the ribose cyclophosphate moiety, and at the exocyclic oxygen atoms, but the atoms which are recognized are different in both sites. The guaninc moiety is recognized in the pyrimidine ring, but not in the imidazole ring; this may explain why CAMP is not recognized at either site.
Activation mechanism
Binding of cGMP to the activator site induces an alteration at the catalytic site by which substrate is bound more easily (rcduction of Km). We observed that the extent to which the cGMP derivatives activate the enzyme is different for each derivative. This may imply that many states of the catalytic site with different K, values exist; the state depends on the molecular structure of the cGMP derivative at the activator site. On the other hand, the results are more easily explained by the assumption that the catalytic site can exist in only two states E and E* with respectively high and low Km. Activation of the enzyme may then proceed via the cyclic scheme, where A is the activator (cGMP or a cGMP derivative), K is the equilibrium constant of E and E* ( K = [E]/[E*]), and Kd is the dissociation constant of EA. If this activation process is a closed thermodynamic system, then p = y. In this scheme the extent of activation depends mainly on the values of K and b. p is the difference in affinity of the cGMP derivative between the non-activated enzyme species E and the activated enzyme species E*. Since these binding affinities depend on the molecular structure of cGMP, p will be different for each derivate.
The model predicts that a complete range of activation folds can be expected if the ratio of affinities of a derivative for E and E* are different. The term 'efficacy' used in pharmacology to explain the relationship between stimulus molecule and the maximal response evoked in a living cell is demonstrated here in a single molecular entity.
